| Abhijit N Desai, MD | |
|
3301 Mercy Health Blvd Ste 125, Cincinnati, OH 45211-1106 | |
| (513) 215-9200 | |
| (513) 215-9259 |
| Full Name | Abhijit N Desai |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 43 Years |
| Location | 3301 Mercy Health Blvd Ste 125, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376542936 | NPI | - | NPPES |
| 2105653 | Medicaid | OH | |
| 200233350 | Medicaid | IN | |
| 64009046 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 35.056320 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Mercy Health - Fairfield Hospital | Fairfield, OH | Hospital |
| Dearborn County Hospital | Lawrenceburg, IN | Hospital |
| Bethesda North | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Physicians Cincinnati Specialty Care Llc | 3971907759 | 294 |
| Mercy Health Physicians Cincinnati Specialty Care Llc | 3971907759 | 294 |
News Archive
If you do something positive for your mate, does it matter why? The answer is yes, according to new research from University of Rochester research assistant professor Heather Patrick.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment.
› Verified 6 days ago
| Entity Name | Mercy Health Physicians Cincinnati Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205887023 PECOS PAC ID: 6709790892 Enrollment ID: O20031113000395 |
News Archive
If you do something positive for your mate, does it matter why? The answer is yes, according to new research from University of Rochester research assistant professor Heather Patrick.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment.
› Verified 6 days ago
| Entity Name | Mercy Health Physicians Cincinnati Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154942795 PECOS PAC ID: 3971907759 Enrollment ID: O20210802003370 |
News Archive
If you do something positive for your mate, does it matter why? The answer is yes, according to new research from University of Rochester research assistant professor Heather Patrick.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abhijit N Desai, MD 3301 Mercy Health Blvd Ste 125, Cincinnati, OH 45211-1106 Ph: (513) 215-9200 | Abhijit N Desai, MD 3301 Mercy Health Blvd Ste 125, Cincinnati, OH 45211-1106 Ph: (513) 215-9200 |
News Archive
If you do something positive for your mate, does it matter why? The answer is yes, according to new research from University of Rochester research assistant professor Heather Patrick.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment.
› Verified 6 days ago
Moises Arturo Huaman Joo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman Street, Cincinnati, OH 45219 Phone: 513-584-6977 Fax: 513-584-4281 | |
Dr. Kiranmayee Lanka, M.D., M.P.H Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Suite 401, Cincinnati, OH 45219 Phone: 513-241-5489 Fax: 513-241-5490 | |
Dr. Saurabh Chandra, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-558-1000 | |
Gretchen Suarez, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10500 Montgomery Rd, Cincinnati, OH 45242 Phone: 513-865-2246 Fax: 513-865-5596 | |
Dr. Andrew Michael Espinal, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4777 E Galbraith Rd, Cincinnati, OH 45236 Phone: 513-686-3000 | |
Sorina M Macavei, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 463 Ohio Pike, Suite 300, Cincinnati, OH 45255 Phone: 513-528-5600 Fax: 513-528-9716 | |
Helen K Koselka, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-528-5600 Fax: 513-528-9716 |